TY - JOUR
T1 - The contribution of hospital-acquired infections to the COVID-19 epidemic in England in the first half of 2020
AU - ISARIC4C Investigators
AU - CMMID COVID-19 Working Group
AU - Knight, Gwenan M.
AU - Pham, Thi Mui
AU - Stimson, James
AU - Funk, Sebastian
AU - Jafari, Yalda
AU - Pople, Diane
AU - Evans, Stephanie
AU - Yin, Mo
AU - Brown, Colin S.
AU - Bhattacharya, Alex
AU - Hope, Russell
AU - Semple, Malcolm G.
AU - Abbott, Sam
AU - Gimma, Amy
AU - Gibbs, Hamish P.
AU - Abbas, Kaja
AU - Barnard, Rosanna C.
AU - Sandmann, Frank G.
AU - Bosse, Nikos I.
AU - Mee, Paul
AU - McCarthy, Ciara V.
AU - Quaife, Matthew
AU - Kucharski, Adam J.
AU - Jarvis, Christopher I.
AU - Hellewell, Joel
AU - Finch, Emilie
AU - Rosello, Alicia
AU - Jit, Mark
AU - Pung, Rachael
AU - Eggo, Rosalind M.
AU - Endo, Akira
AU - Medley, Graham
AU - Tully, Damien C.
AU - Wong, Kerry L.M.
AU - Liu, Yang
AU - Sherratt, Katharine
AU - Munday, James D.
AU - Chapman, Lloyd A.C.
AU - Hué, Stéphane
AU - O’Reilly, Kathleen
AU - Davies, Nicholas G.
AU - Meakin, Sophie R.
AU - Sun, Fiona Yueqian
AU - Brady, Oliver
AU - Villabona-Arenas, C. Julian
AU - Atkins, Katherine E.
AU - Prem, Kiesha
AU - Hodgson, David
AU - Koltai, Mihaly
AU - Robotham, Julie V.
N1 - Publisher Copyright:
© 2022, The Author(s).
PY - 2022/12
Y1 - 2022/12
N2 - Background: SARS-CoV-2 is known to transmit in hospital settings, but the contribution of infections acquired in hospitals to the epidemic at a national scale is unknown. Methods: We used comprehensive national English datasets to determine the number of COVID-19 patients with identified hospital-acquired infections (with symptom onset > 7 days after admission and before discharge) in acute English hospitals up to August 2020. As patients may leave the hospital prior to detection of infection or have rapid symptom onset, we combined measures of the length of stay and the incubation period distribution to estimate how many hospital-acquired infections may have been missed. We used simulations to estimate the total number (identified and unidentified) of symptomatic hospital-acquired infections, as well as infections due to onward community transmission from missed hospital-acquired infections, to 31st July 2020. Results: In our dataset of hospitalised COVID-19 patients in acute English hospitals with a recorded symptom onset date (n = 65,028), 7% were classified as hospital-acquired. We estimated that only 30% (range across weeks and 200 simulations: 20–41%) of symptomatic hospital-acquired infections would be identified, with up to 15% (mean, 95% range over 200 simulations: 14.1–15.8%) of cases currently classified as community-acquired COVID-19 potentially linked to hospital transmission. We estimated that 26,600 (25,900 to 27,700) individuals acquired a symptomatic SARS-CoV-2 infection in an acute Trust in England before 31st July 2020, resulting in 15,900 (15,200–16,400) or 20.1% (19.2–20.7%) of all identified hospitalised COVID-19 cases. Conclusions: Transmission of SARS-CoV-2 to hospitalised patients likely caused approximately a fifth of identified cases of hospitalised COVID-19 in the “first wave” in England, but less than 1% of all infections in England. Using time to symptom onset from admission for inpatients as a detection method likely misses a substantial proportion (> 60%) of hospital-acquired infections.
AB - Background: SARS-CoV-2 is known to transmit in hospital settings, but the contribution of infections acquired in hospitals to the epidemic at a national scale is unknown. Methods: We used comprehensive national English datasets to determine the number of COVID-19 patients with identified hospital-acquired infections (with symptom onset > 7 days after admission and before discharge) in acute English hospitals up to August 2020. As patients may leave the hospital prior to detection of infection or have rapid symptom onset, we combined measures of the length of stay and the incubation period distribution to estimate how many hospital-acquired infections may have been missed. We used simulations to estimate the total number (identified and unidentified) of symptomatic hospital-acquired infections, as well as infections due to onward community transmission from missed hospital-acquired infections, to 31st July 2020. Results: In our dataset of hospitalised COVID-19 patients in acute English hospitals with a recorded symptom onset date (n = 65,028), 7% were classified as hospital-acquired. We estimated that only 30% (range across weeks and 200 simulations: 20–41%) of symptomatic hospital-acquired infections would be identified, with up to 15% (mean, 95% range over 200 simulations: 14.1–15.8%) of cases currently classified as community-acquired COVID-19 potentially linked to hospital transmission. We estimated that 26,600 (25,900 to 27,700) individuals acquired a symptomatic SARS-CoV-2 infection in an acute Trust in England before 31st July 2020, resulting in 15,900 (15,200–16,400) or 20.1% (19.2–20.7%) of all identified hospitalised COVID-19 cases. Conclusions: Transmission of SARS-CoV-2 to hospitalised patients likely caused approximately a fifth of identified cases of hospitalised COVID-19 in the “first wave” in England, but less than 1% of all infections in England. Using time to symptom onset from admission for inpatients as a detection method likely misses a substantial proportion (> 60%) of hospital-acquired infections.
KW - COVID-19
KW - Mathematical modelling
KW - Nosocomial transmission
KW - SARS-CoV-2
UR - https://www.scopus.com/pages/publications/85132455783
U2 - 10.1186/s12879-022-07490-4
DO - 10.1186/s12879-022-07490-4
M3 - Article
C2 - 35717168
AN - SCOPUS:85132455783
SN - 1471-2334
VL - 22
JO - BMC Infectious Diseases
JF - BMC Infectious Diseases
IS - 1
M1 - 556
ER -